Collectively, the Ldb2 KO mice at least partly fulfill the criteria of both face validity (a similarity exists between behavioral phenotypes of a model animal and disease symptoms) and predictive validity (a drug used for a disease is also effective to ameliorate phenotypes of a model animal) for schizophrenia and bipolar mania. The gene discussed is LDB2; the disease is schizophrenia.